Gradient Denervation Technologies

medical devices

About

Gradient Denervation Technologies is a medical device company based in Paris, specializing in solutions for pulmonary hypertension, particularly that caused by left-sided heart disease. The company has developed the Pulmonary Artery Denervation (PADN) System, which utilizes therapeutic ultrasound energy delivered through a percutaneous catheter to ablate nerves around the pulmonary artery. This process aims to reduce vascular resistance and lower pulmonary arterial pressures. The PADN system has received the FDA Breakthrough Device designation, which supports its expedited review due to its potential to improve treatment for a serious condition. Gradient Denervation Technologies is currently enrolling patients in the PreVail-PH2 early feasibility study in the United States to validate the safety and efficacy of its device. The company is privately held and operates with fewer than 25 employees, backed by Sofinnova Partners through the MD Start III Fund.

Technologies

Outlook Microsoft Office 365 WordPress.org Typekit Mobile Friendly IoT Android Render Node.js Circle Deel Vincere AI Remote

Keywords

heart failure b2b pulmonary hypertension treatment gap medical equipment and supplies manufacturing ultrasound ablation ultrasound-based therapy ultrasound energy pulmonary pressure fda breakthrough designation cpcph fda breakthrough minimally invasive device pulmonary hypertension device development targeted therapy pulmonary vascular resistance pulmonary artery nerves pulmonary artery denervation system pulmonary artery anatomy medical devices pulmonary hypertension treatment pulmonary hypertension innovation pulmonary hypertension intervention clinical development stanford university technology pulmonary hypertension device pulmonary hypertension therapy pulmonary hypertension pulmonary artery denervation healthcare technology medical device innovation

Location

11 Boulevard Haussmann, Paris, Ile-de-France, France, 75009

Related Companies

Companies in the same industry